Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

November 1, 2019

Study Completion Date

November 1, 2019

Conditions
CancerSkin FibroblastsMuscle Weakness
Interventions
DIETARY_SUPPLEMENT

Nicotinamide Riboside (NR)

Niacin is a form of vitamin B3 and has been used to treat hypercholesterolemia for many years. There is growing evidence that nicotinamide adenine dinucleotide (NAD+ can maintain mitochondria through various mechanisms and that it is possible to improve mitochondrial function by dietary supplementation with the vitamin B3 analogue nicotinamide riboside (NR), an intermediate in the NAD+ salvage pathway. We have observed that culturing the fibroblasts of a LFS patient with mitochondrial deficiency in medium containing NR rescues the defect in mitochondrial respiration.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT03789175 - Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome | Biotech Hunter | Biotech Hunter